Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Direct thrombin inhibitor argatroban reduces stroke damage in 2 different models.

Lyden P, Pereira B, Chen B, Zhao L, Lamb J, Lei IF, Rajput P.

Stroke. 2014 Mar;45(3):896-9. doi: 10.1161/STROKEAHA.113.004488.

2.

Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.

Morris DC, Zhang L, Zhang ZG, Lu M, Berens KL, Brown PM, Chopp M.

Stroke. 2001 Nov;32(11):2635-40.

3.

Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.

Kawai H, Yuki S, Sugimoto J, Tamao Y.

J Pharmacol Exp Ther. 1996 Aug;278(2):780-5.

PMID:
8768731
4.

Thrombin activity associated with neuronal damage during acute focal ischemia.

Chen B, Friedman B, Whitney MA, Winkle JA, Lei IF, Olson ES, Cheng Q, Pereira B, Zhao L, Tsien RY, Lyden PD.

J Neurosci. 2012 May 30;32(22):7622-31. doi: 10.1523/JNEUROSCI.0369-12.2012.

6.

Argatroban in thrombotic stroke.

LaMonte MP.

Pathophysiol Haemost Thromb. 2002;32 Suppl 3:39-45. Review.

PMID:
12811011
7.

Argatroban attenuates leukocyte- and platelet-endothelial cell interactions after transient retinal ischemia.

Miyahara S, Kiryu J, Tsujikawa A, Katsuta H, Nishijima K, Miyamoto K, Yamashiro K, Nonaka A, Honda Y.

Stroke. 2003 Aug;34(8):2043-9.

8.

Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor.

LaMonte MP, Brown PM, Hursting MJ.

Expert Rev Cardiovasc Ther. 2005 Jan;3(1):31-41. Review.

PMID:
15723573
9.

Thrombin inhibition in the acute phase of ischaemic stroke using argatroban.

Kario K, Kodama K, Koide M, Matsuo T.

Blood Coagul Fibrinolysis. 1995 Jul;6(5):423-7.

PMID:
8589208
10.

Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage.

Kitaoka T, Hua Y, Xi G, Hoff JT, Keep RF.

Stroke. 2002 Dec;33(12):3012-8.

11.

Mild hypothermia enhances the neuroprotective effects of a selective thrombin inhibitor following transient focal ischemia in rats.

Kamiya T, Nito C, Ueda M, Kato K, Amemiya S, Terashi A, Katayama Y.

Acta Neurochir Suppl. 2003;86:195-8.

PMID:
14753434
12.

Neuroprotective effects of argatroban and C5a receptor antagonist (PMX53) following intracerebral haemorrhage.

Li G, Fan RM, Chen JL, Wang CM, Zeng YC, Han C, Jiao S, Xia XP, Chen W, Yao ST.

Clin Exp Immunol. 2014 Feb;175(2):285-95. doi: 10.1111/cei.12220.

13.

Preventive effect of argatroban on ellagic acid-induced cerebral thromboembolism in rats.

Hara T, Iwamoto M, Ishihara M, Tomikawa M.

Haemostasis. 1994 Nov-Dec;24(6):351-7.

PMID:
7843647
14.

Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study.

LaMonte MP, Nash ML, Wang DZ, Woolfenden AR, Schultz J, Hursting MJ, Brown PM; ARGIS-1 Investigators..

Stroke. 2004 Jul;35(7):1677-82.

15.
16.

Strategies to improve post-stroke behavioral recovery in aged subjects.

Buga AM, Bălşeanu A, Popa-Wagner A, Mogoantă L.

Rom J Morphol Embryol. 2009;50(4):559-82.

18.

Effect of delayed argatroban treatment on intracerebral hemorrhage-induced edema in the rat.

Kitaoka T, Hua Y, Xi G, Nagao S, Hoff JT, Keep RF.

Acta Neurochir Suppl. 2003;86:457-61.

PMID:
14753486
19.

Mannose-binding lectin promotes local microvascular thrombosis after transient brain ischemia in mice.

de la Rosa X, Cervera A, Kristoffersen AK, Valdés CP, Varma HM, Justicia C, Durduran T, Chamorro Á, Planas AM.

Stroke. 2014 May;45(5):1453-9. doi: 10.1161/STROKEAHA.113.004111.

20.
Items per page

Supplemental Content

Support Center